VVigilance Weekly공개 리포트 보기
← 이번 주 리포트
tirzepatide우선순위 낮음근거 검토기타

LITERATURE DETAIL · PMID 42556625

The role of GLP-1 and GIP receptor agonists in the treatment of diabetes and obesity.

The role of GLP-1 and GIP receptor agonists in the treatment of diabetes and obesity.

저자
Robert Roskoski
저널
Pharmacological research
공개일
2026 Aug 05
연구 유형
기타
DOI
10.1016/j.phrs.2026.108365

문헌 요약

Owing to the therapeutic success of glucagon-like peptide-1 receptor (GLP-1R) and glucose-dependent insulinotropic polypeptide receptor (GIPR) agonists in the management of diabetes and obesity, the pharmacology of these drugs and their receptors has engendered considerable interest. GLP-1 and GIP are incretin hormones so named owing to their ability to i…

PV 검토 포인트

누적 안전성 근거로 분류하고 기존 시그널과의 일관성을 확인합니다.

PubMed에서 원문 정보 보기